Ablation Clinical Trials in Nanjing, Jiangsu
2 recruitingNanjing, Jiangsu, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University276 enrolled1 locationNCT06762782
Recruiting
Not Applicable
CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)
AblationLong-standing Persistent Atrial Fibrillation
The First Affiliated Hospital with Nanjing Medical University320 enrolled10 locationsNCT06516822